Suchergebnisse - "Capdevila, Jaume"

PubPharm (38)

1

Increased Progression-Free Survival with Cabozantinib Versus Placebo in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Irrespective of Prior Vascular Endothelial Growth Factor Receptor-Targeted Therapy and Tumor Histology : A Subgroup Analysis of the COSMIC-311 Study

enthalten in: Thyroid : official journal of the American Thyroid Association | 2024

von Capdevila, J. | Krajewska, J. | Hernando, J. | +13

2

Phase 3 Trial of Selpercatinib in Advanced RET-Mutant Medullary Thyroid Cancer

enthalten in: The New England journal of medicine | 2023

von Hadoux, J. | Elisei, R. | Brose, M. | +122

3

Use of lenvatinib in the treatment of radioiodine-refractory differentiated thyroid cancer : a multidisciplinary perspective for daily practice

enthalten in: European thyroid journal | 2023

von Capdevila, J. | Deandreis, D. | Durante, C. | +9

4

Cabozantinib for previously treated radioiodine-refractory differentiated thyroid cancer : Updated results from the phase 3 COSMIC-311 trial

enthalten in: Cancer | 2022

von Brose, M. | Robinson, B. | Sherman, S. | +11

ErratumIn: Cancer. 2023 Jan 13;:. - PMID 36637398

5

A Randomized, Double-Blind Noninferiority Study to Evaluate the Efficacy of the Cabozantinib Tablet at 60 mg Per Day Compared with the Cabozantinib Capsule at 140 mg Per Day in Patients with Progressive, Metastatic Medullary Thyroid Cancer

enthalten in: Thyroid : official journal of the American Thyroid Association | 2022

von Capdevila, J. | Klochikhin, A. | Leboulleux, S. | +15

6

Efficacy and safety of high-dose lanreotide autogel in patients with progressive pancreatic or midgut neuroendocrine tumours : CLARINET FORTE phase 2 study results

enthalten in: European journal of cancer (Oxford, England : 1990) | 2021

von Pavel, M. | Ćwikła, J. | Lombard-Bohas, C. | +8

7

Correlation of Performance Status and Neutrophil-Lymphocyte Ratio with Efficacy in Radioiodine-Refractory Differentiated Thyroid Cancer Treated with Lenvatinib

enthalten in: Thyroid : official journal of the American Thyroid Association | 2021

von Taylor, M. | Takahashi, S. | Capdevila, J. | +10

8

Lenvatinib in Patients With Advanced Grade 1/2 Pancreatic and Gastrointestinal Neuroendocrine Tumors : Results of the Phase II TALENT Trial (GETNE1509)

enthalten in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology | 2021

von Capdevila, J. | Fazio, N. | Lopez, C. | +26

9

Phase I Study of Lysine-Specific Demethylase 1 Inhibitor, CC-90011, in Patients with Advanced Solid Tumors and Relapsed/Refractory Non-Hodgkin Lymphoma

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2021

von Hollebecque, A. | Salvagni, S. | Plummer, R. | +18

10

Evaluating radiological response in pancreatic neuroendocrine tumours treated with sunitinib : comparison of Choi versus RECIST criteria (CRIPNET_ GETNE1504 study)

enthalten in: British journal of cancer | 2019

von Solis-Hernandez, M. | Fernandez Del Valle, A. | Carmona-Bayonas, A. | +15